Elicio Therapeutics (ELTX) Earnings Analysis
Elicio Therapeutics (ELTX) next reports earnings on 2026-08-06, consensus EPS -0.53 USD. Last quarter (2026-05-11) it missed with EPS -0.65 USD vs -0.49 USD est (-32.7%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -1.32.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ELTX next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.53 USD |
| Revenue estimate | n/a |
ELTX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.65 USD | -0.49 USD | -32.7% | Miss |
| 2026-03-12 | -0.49 USD | -0.47 USD | -4.3% | Miss |
| 2025-11-13 | -0.6 USD | -0.62 USD | +3.2% | Beat |
| 2025-03-31 | -1.02 USD | -0.94 USD | -8.5% | Miss |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
ELTX valuation and analyst view
| Trailing P/E | -1.32 |
|---|---|
| Trailing EPS | -2.20654 USD |
| Price / book | -39.54 |
| Dividend yield | 0.00% |
| Market cap | 0.06B |
| Analyst consensus | Hold (1 buy / 2 hold / 0 sell) |
| Avg price target | 17 USD |
Related research pages
Frequently asked questions
When is Elicio Therapeutics (ELTX)'s next earnings date?
Elicio Therapeutics is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.53 USD.
Did ELTX beat earnings last quarter?
In its 2026-05-11 report, ELTX posted EPS of -0.65 USD versus a -0.49 USD estimate — a miss of 32.7%.
What is ELTX's earnings track record?
Over the last 4 reported quarters with consensus data, ELTX beat estimates 1 times (25%).
What is ELTX's current P/E ratio and EPS?
ELTX trades at a trailing P/E of -1.32 on trailing EPS of -2.206543085245263 USD.
What do analysts rate ELTX?
Analyst consensus is "Hold" across 3 ratings (0 strong buy, 1 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 17 USD.